For citations:
Mamedov M.N., Kolchina М.A. EVALUATING THE USE OF PITAVASTATIN IN TYPE 2 DIABETES MELLITUS AND HIGH CARDIOVASCULAR RISK: CLINICAL CASE. Aterotromboz = Atherothrombosis. 2018;(1):132-139. (In Russ.) https://doi.org/10.21518/2307-1109-2018-1-132-139
This work is licensed under a Creative Commons Attribution Attribution-NonCommercial-NoDerivs License.
Email this article 